Review summary
Teaching objective: Pernicious anemia in an older man with old frostbite amputations: a 62-year-old retired naval officer and polar explorer comes in with four months of fatigue, breathlessness, pallor, a sore tongue and numb, unsteady feet. The episode covers the blood count, MCV, smear and reticulocytes; vitamin B12, methylmalonic acid, homocysteine and folate; iron studies; intrinsic factor and parietal cell antibodies and gastrin; treatment without delay when nerves are affected, with intramuscular cyanocobalamin loading, a weekly phase and lifelong monthly maintenance under the 1907 British Society for Haematology guideline and the 1917 NICE guideline, and high-dose oral therapy as an alternative; the reticulocyte response and the risk of low potassium early in treatment; restrictive transfusion; upper endoscopy for neuroendocrine tumors and gastric cancer risk and its surveillance under the 1914 AGA clinical practice update on atrophic gastritis; screening for autoimmune thyroid disease and diabetes; iron deficiency unmasked by recovery; the examination of subacute combined degeneration and its partial recovery; neuropathy and falls; and foot care for a man with old toe amputations, with footwear, daily skin checks and podiatry.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| May 6, 1856 | Born in Cresson, Pennsylvania; his father dies within three years and his mother raises him in Maine. | CLM-0001 |
| 1877 | Graduates from Bowdoin College as a civil engineer; later joins the Navy Civil Engineer Corps and hires Matthew Henson in Nicaragua. | CLM-0002 |
| 1886 | First of eight Arctic expeditions, carried out with the help of Inughuit men and women. | CLM-0003 |
| 1888 | Marries; two children follow. | CLM-0008 |
| July 11, 1891 | Breaks both bones of a leg above the ankle aboard the Kite. | CLM-0004 |
| 1897 | Brings six Inughuit people to New York; four die within months. | CLM-0005 |
| January 6, 1899 | Both feet frozen on reaching Fort Conger, Ellesmere Island; most of his toes amputated in March. | CLM-0006, CLM-0007 |
| 1900 | Has two sons with an Inughuit woman in Greenland during the expeditions of these years. | CLM-0008 |
| April 6, 1909 | Reports reaching the North Pole with Matthew Henson and four Inughuit men; the claim is disputed. | CLM-0009 |
| 1911 | Retires as a rear admiral; lives in Washington, D.C., with summers on Eagle Island, Maine. | CLM-0010 |
| February 20, 1920 | Dies of pernicious anemia; buried at Arlington National Cemetery. Liver therapy, the first effective treatment, came only after his death. | CLM-0013, CLM-0014 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Robert Edwin Peary was born on May 6, 1856, in Cresson, Pennsylvania. His father died within three years of his birth, and his mother raised him in southern Maine. | confirmed | Robert E. Peary (Arctic biographies) supports Weems JE. Arctic Profiles: Robert Edwin Peary (1856-1920). Arctic 1982;35(4):556 supports HISTMED Master Roster v3 context |
| D | He graduated from Bowdoin College as a civil engineer in 1877, joined the Coast and Geodetic Survey in Washington in 1879 and the U.S. Navy Civil Engineer Corps in 1881, and surveyed in Nicaragua for a proposed canal; there he hired Matthew Henson, the African American who proved indispensable to his Arctic work. Anchors his background as an engineer and naval officer. |
confirmed | Robert E. Peary (Arctic biographies) supports Weems JE. Arctic Profiles: Robert Edwin Peary (1856-1920). Arctic 1982;35(4):556 supports |
| D | From 1886 to 1909 he planned and led eight Arctic expeditions, one of them four years long, relying on the help of Inughuit (Polar Inuit) men and women of northwestern Greenland, who hunted, sledged, sewed and overwintered with his parties. On the 1891 to 1892 expedition he showed that Greenland is an island. History of his work and of the Inughuit people whose labor made the expeditions possible; no health fact about any of them is recorded. |
confirmed | Weems JE. Arctic Profiles: Robert Edwin Peary (1856-1920). Arctic 1982;35(4):556 supports LeMoine G. Elatu's Funeral: A Glimpse of Inughuit-American Relations on Robert E. Peary's 1898-1902 Expedition. Arctic 2014;67(3):340-346 supports Robert E. Peary (Arctic biographies) supports |
| D | On July 11, 1891, aboard the Kite in the ice of Melville Bay, the iron tiller, jammed over by an ice cake, caught his leg against the deckhouse and broke both bones just above the ankle; the leg was set and he was carried ashore at the winter camp. Past injury; the healed fracture is recorded in the past medical history. |
confirmed | 1891 - Melville Bay Ice Pack; A Broken Leg (Polar Pathways: Robert E. Peary's Arctic Expeditions) supports |
| D | In 1897, at the request of staff of the American Museum of Natural History, who had asked for one Inughuit man to work with the museum for a year, he brought six Inughuit people from Greenland to New York: three men, a woman and two children. Within months four of them had died; a boy of about seven, whose father was among the dead, was left an orphan far from home, and the museum kept his father's bones instead of burying them. A documented part of his treatment of Inuit people, recorded plainly. It has no clinical role in the modern episode; no health fact about any of the six is recorded. |
confirmed | Caught in the Middle: The Tragic Life of Minik Wallace supports |
| D | On the expedition of 1898 to 1902, reaching the old station at Fort Conger on Ellesmere Island at midnight on January 6, 1899, he found that both feet were frozen; in March a doctor amputated the affected toes. He lost most of his toes, and the stumps were often left bloody and aching by knocks against rough ice on later journeys. Anchors the synthetic toe amputations, the forefoot care and the importance of foot protection in the modern episode. |
confirmed | 1898 to Fort Conger: Demise of Peary's Toes (Polar Pathways: Robert E. Peary's Arctic Expeditions) supports Weems JE. Arctic Profiles: Robert Edwin Peary (1856-1920). Arctic 1982;35(4):556 supports LeMoine G. Elatu's Funeral: A Glimpse of Inughuit-American Relations on Robert E. Peary's 1898-1902 Expedition. Arctic 2014;67(3):340-346 supports |
| R | The number of toes he lost is uncertain: the roster says eight, and a historian of the expedition notes that the exact number and circumstances have been mythologized. The synthetic modern record gives a number (toes two to five on each foot); it is not a claim about the real count. |
disputed | LeMoine G. Elatu's Funeral: A Glimpse of Inughuit-American Relations on Robert E. Peary's 1898-1902 Expedition. Arctic 2014;67(3):340-346 supports HISTMED Master Roster v3 context |
| D | He married in 1888 and had two children with his wife. He also had two sons with an Inughuit woman in Greenland, born during his expeditions; his daughter's papers name them as her half-brothers, and one of them was an infant in the winter of 1900 to 1901. Documented family history recorded plainly as history; no relative has any statement, decision or health fact in the modern episode, and no descendant is named. |
confirmed | Weems JE. Arctic Profiles: Robert Edwin Peary (1856-1920). Arctic 1982;35(4):556 supports Marie Ahnighito Peary papers, 1862-1995 (finding aid) supports |
| D | On April 6, 1909, he reported reaching the North Pole with Matthew Henson and four Inughuit men, Ootah, Egingwah, Seegloo and Ooqueah (Odaq, Iggianguaq, Sigluk and Ukkujaaq in today's spelling). Frederick Cook announced a competing claim days before Peary returned; most geographic bodies came to credit Peary, but the claim has long been disputed. History of his work and of his companions; the dispute is a documented fact, not a health fact. |
confirmed | Robert E. Peary (Arctic biographies) supports Weems JE. Arctic Profiles: Robert Edwin Peary (1856-1920). Arctic 1982;35(4):556 supports Notable Graves: Explorers supports |
| D | He retired from the Navy in 1911 as a rear admiral with the Thanks of Congress, and lived his last years with his family in Washington, D.C., spending summers on Eagle Island on the Maine coast; the dispute over his claim cast a pall over those years. Anchors the setting and the social history of the modern episode. |
confirmed | Robert E. Peary (Arctic biographies) supports Weems JE. Arctic Profiles: Robert Edwin Peary (1856-1920). Arctic 1982;35(4):556 supports Notable Graves: Explorers supports |
| D | He died on February 20, 1920, of pernicious anemia, and was buried at Arlington National Cemetery, where Matthew Henson was later reinterred beside him. Anchors the modern diagnosis of pernicious anemia in the last years of his life; the timing of its onset and its treatment are not documented in the sources read. |
confirmed | Weems JE. Arctic Profiles: Robert Edwin Peary (1856-1920). Arctic 1982;35(4):556 supports Robert E. Peary (Arctic biographies) supports Notable Graves: Explorers supports HISTMED Master Roster v3 context |
| D | Liver therapy for pernicious anemia, the first effective treatment, was discovered only after his death; George Whipple, George Minot and William Murphy shared the 1934 Nobel Prize in Physiology or Medicine for it. Context: in his lifetime pernicious anemia had no effective treatment; the modern episode shows how it is treated now. |
confirmed | The Nobel Prize in Physiology or Medicine 1934 (summary) supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Fatigue, breathlessness on exertion, pallor with a lemon-yellow tinge, a sore tongue, and numbness and unsteadiness in the feet over about four months, with a macrocytic anemia, low white cells and platelets, a low vitamin B12 and a high methylmalonic acid; cause under evaluation with a hematology consultation | resolved | confirmed | active | CLM-0013 |
| S | Pernicious anemia (autoimmune gastritis with intrinsic factor antibodies), with severe vitamin B12 deficiency; synthetic modern diagnosis linked to the documented cause of his death | active | confirmed | both_with_link | CLM-0013 |
| S | Subacute combined degeneration of the spinal cord with peripheral neuropathy from vitamin B12 deficiency: loss of vibration and joint position sense in the feet, absent ankle jerks, brisk knee jerks and a positive Romberg test | active | confirmed | active | CLM-0013 |
| S | Absence of the second to fifth toes of the right foot after frostbite and amputation in early middle age; healed stumps; callus under the first metatarsal head | active | confirmed | both_with_link | CLM-0006, CLM-0007 |
| S | Absence of the second to fifth toes of the left foot after frostbite and amputation in early middle age; healed stumps | active | confirmed | both_with_link | CLM-0006, CLM-0007 |
| S | One fall in a dark bedroom a month ago without injury; unsteady in the dark and on uneven ground; uses a stick outdoors | active | confirmed | active | CLM-0006, CLM-0007 |
| S | Autoimmune atrophic gastritis, corpus-predominant, with intestinal metaplasia and enterochromaffin-like cell hyperplasia in the body of the stomach, a spared antrum, no Helicobacter pylori, no neuroendocrine tumor and no dysplasia | active | confirmed | active | CLM-0013 |
| S | Iron deficiency without anemia, unmasked by the recovery of red cell production and the poor iron absorption of atrophic gastritis; colonoscopy and endoscopy without a bleeding source | active | confirmed | active | CLM-0013 |
| S | Blister on the end of the left forefoot over the old amputation stump, from boots not yet broken in, in a foot with reduced sensation; no infection; healed in two weeks | resolved | confirmed | active | CLM-0006, CLM-0007 |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 1919-01-13 | Hemoglobin [Mass/volume] in Blood | 8.2 g/dL (low) Reference 13.2-17.1 g/dL |
http://loinc.org · 718-7 |
| S | 1919-01-13 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 118 fL (high) Reference 80-100 fL |
http://loinc.org · 787-2 |
| S | 1919-01-13 | Erythrocyte [DistWidth] in Blood by Automated count | 19.6% (high) Reference 11-15% |
http://loinc.org · 788-0 |
| S | 1919-01-13 | Leukocytes [#/volume] in Blood by Automated count | 3.4 10*3/uL (low) Reference 3.8-10.8 10*3/uL |
http://loinc.org · 6690-2 |
| S | 1919-01-13 | Platelets [#/volume] in Blood by Automated count | 118 10*3/uL (low) Reference 140-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 1919-01-13 | Reticulocytes/Erythrocytes in Blood by Automated count | 0.4% (low) Reference 0.5-2.5% |
http://loinc.org · 17849-1 |
| S | 1919-01-13 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma | 1240 U/L (high) Reference 120-250 U/L |
http://loinc.org · 2532-0 |
| S | 1919-01-13 | Bilirubin.total [Mass/volume] in Serum or Plasma | 1.9 mg/dL (high) Reference 0.2-1.2 mg/dL |
http://loinc.org · 1975-2 |
| S | 1919-01-13 | Sodium [Moles/volume] in Serum or Plasma | 139 mmol/L Reference 135-146 mmol/L |
http://loinc.org · 2951-2 |
| S | 1919-01-13 | Potassium [Moles/volume] in Serum or Plasma | 4.1 mmol/L Reference 3.5-5.3 mmol/L |
http://loinc.org · 2823-3 |
| S | 1919-01-13 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 mg/dL Reference 0.7-1.3 mg/dL |
http://loinc.org · 2160-0 |
| S | 1919-01-13 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1914)/1.73 sq M | 85 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1919-01-13 | Glucose [Mass/volume] in Serum or Plasma | 92 mg/dL Reference 65-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1919-01-13 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 96 pg/mL (low) Reference 200-1100 pg/mL |
http://loinc.org · 2132-9 |
| S | 1919-01-13 | Folate [Mass/volume] in Serum or Plasma | 14.2 ng/mL Reference >=5.4 ng/mL |
http://loinc.org · 2284-8 |
| S | 1919-01-13 | Methylmalonate [Moles/volume] in Serum or Plasma | 3.1 umol/L (high) Reference <=0.4 umol/L |
http://loinc.org · 13964-2 |
| S | 1919-01-13 | Homocysteine [Moles/volume] in Serum or Plasma | 38 umol/L (high) Reference <=15 umol/L |
http://loinc.org · 13965-9 |
| S | 1919-01-13 | Ferritin [Mass/volume] in Serum or Plasma | 62 ng/mL Reference 30-400 ng/mL |
http://loinc.org · 2276-4 |
| S | 1919-01-13 | Iron [Mass/volume] in Serum or Plasma | 148 ug/dL Reference 50-180 ug/dL |
http://loinc.org · 2498-4 |
| S | 1919-01-13 | Iron binding capacity [Mass/volume] in Serum or Plasma | 268 ug/dL Reference 250-425 ug/dL |
http://loinc.org · 2500-7 |
| S | 1919-01-13 | Iron saturation [Mass Fraction] in Serum or Plasma | 55% (high) Reference 20-50% |
http://loinc.org · 2502-3 |
| S | 1919-01-13 | Thyrotropin [Units/volume] in Serum or Plasma | 2.6 mIU/L Reference 0.4-4.5 mIU/L |
http://loinc.org · 3016-3 |
| S | 1919-01-13 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5% Reference <=5.6% |
http://loinc.org · 4548-4 |
| S | 1919-01-13 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | http://loinc.org · 44261-6 |
| S | 1919-01-13 | Total score [MoCA] | 27 | http://loinc.org · 72172-0 |
| S | 1919-01-13 | Total score [AUDIT-C] | 2 | http://loinc.org · 75626-2 |
| S | 1919-01-21 | Hemoglobin [Mass/volume] in Blood | 8.9 g/dL (low) Reference 13.2-17.1 g/dL |
http://loinc.org · 718-7 |
| S | 1919-01-21 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 114 fL (high) Reference 80-100 fL |
http://loinc.org · 787-2 |
| S | 1919-01-21 | Leukocytes [#/volume] in Blood by Automated count | 4.6 10*3/uL Reference 3.8-10.8 10*3/uL |
http://loinc.org · 6690-2 |
| S | 1919-01-21 | Platelets [#/volume] in Blood by Automated count | 186 10*3/uL Reference 140-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 1919-01-21 | Reticulocytes/Erythrocytes in Blood by Automated count | 7.9% (high) Reference 0.5-2.5% |
http://loinc.org · 17849-1 |
| S | 1919-01-21 | Potassium [Moles/volume] in Serum or Plasma | 3.6 mmol/L Reference 3.5-5.3 mmol/L |
http://loinc.org · 2823-3 |
| S | 1919-01-21 | Intrinsic factor Ab [Units/volume] in Serum by Immunoassay | 38.5 [arb'U]/mL (high) Reference 1.1 AU/mL or less: negative |
http://loinc.org · 56539-0 |
| S | 1919-01-21 | Parietal cell Ab [Units/volume] in Serum by Immunoassay | 96 [arb'U]/mL (high) Reference Below 20.1: negative |
http://loinc.org · 56147-2 |
| S | 1919-01-21 | Gastrin [Mass/volume] in Serum or Plasma | 820 pg/mL (high) Reference <=100 pg/mL |
http://loinc.org · 2333-3 |
| S | 1919-01-21 | Thyroperoxidase Ab [Units/volume] in Serum or Plasma | 6 [IU]/mL Reference <=8 [IU]/mL |
http://loinc.org · 8099-4 |
| S | 1919-02-17 | Hemoglobin [Mass/volume] in Blood | 12 g/dL (low) Reference 13.2-17.1 g/dL |
http://loinc.org · 718-7 |
| S | 1919-02-17 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 101 fL (high) Reference 80-100 fL |
http://loinc.org · 787-2 |
| S | 1919-02-17 | Leukocytes [#/volume] in Blood by Automated count | 5.6 10*3/uL Reference 3.8-10.8 10*3/uL |
http://loinc.org · 6690-2 |
| S | 1919-02-17 | Platelets [#/volume] in Blood by Automated count | 232 10*3/uL Reference 140-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 1919-02-17 | Reticulocytes/Erythrocytes in Blood by Automated count | 1.6% Reference 0.5-2.5% |
http://loinc.org · 17849-1 |
| S | 1919-02-17 | Potassium [Moles/volume] in Serum or Plasma | 4.3 mmol/L Reference 3.5-5.3 mmol/L |
http://loinc.org · 2823-3 |
| S | 1919-03-10 | Hemoglobin [Mass/volume] in Blood | 14.1 g/dL Reference 13.2-17.1 g/dL |
http://loinc.org · 718-7 |
| S | 1919-03-10 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 91 fL Reference 80-100 fL |
http://loinc.org · 787-2 |
| S | 1919-03-10 | Erythrocyte [DistWidth] in Blood by Automated count | 15.6% (high) Reference 11-15% |
http://loinc.org · 788-0 |
| S | 1919-03-10 | Leukocytes [#/volume] in Blood by Automated count | 6.2 10*3/uL Reference 3.8-10.8 10*3/uL |
http://loinc.org · 6690-2 |
| S | 1919-03-10 | Platelets [#/volume] in Blood by Automated count | 248 10*3/uL Reference 140-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 1919-03-10 | Methylmalonate [Moles/volume] in Serum or Plasma | 0.26 umol/L Reference <=0.4 umol/L |
http://loinc.org · 13964-2 |
| S | 1919-03-10 | Homocysteine [Moles/volume] in Serum or Plasma | 11 umol/L Reference <=15 umol/L |
http://loinc.org · 13965-9 |
| S | 1919-03-10 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma | 190 U/L Reference 120-250 U/L |
http://loinc.org · 2532-0 |
| S | 1919-03-10 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.7 mg/dL Reference 0.2-1.2 mg/dL |
http://loinc.org · 1975-2 |
| S | 1919-03-10 | Ferritin [Mass/volume] in Serum or Plasma | 24 ng/mL (low) Reference 30-400 ng/mL |
http://loinc.org · 2276-4 |
| S | 1919-03-10 | Iron [Mass/volume] in Serum or Plasma | 52 ug/dL Reference 50-180 ug/dL |
http://loinc.org · 2498-4 |
| S | 1919-03-10 | Iron binding capacity [Mass/volume] in Serum or Plasma | 382 ug/dL Reference 250-425 ug/dL |
http://loinc.org · 2500-7 |
| S | 1919-03-10 | Iron saturation [Mass Fraction] in Serum or Plasma | 14% (low) Reference 20-50% |
http://loinc.org · 2502-3 |
| S | 1919-03-24 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 1919-03-24 | Cholesterol [Mass/volume] in Serum or Plasma | 196 mg/dL Reference <=199 mg/dL |
http://loinc.org · 2093-3 |
| S | 1919-03-24 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 58 mg/dL Reference >=40 mg/dL |
http://loinc.org · 2085-9 |
| S | 1919-03-24 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 118 mg/dL (high) Reference <=99 mg/dL |
http://loinc.org · 13457-7 |
| S | 1919-03-24 | Triglyceride [Mass/volume] in Serum or Plasma | 100 mg/dL Reference <=149 mg/dL |
http://loinc.org · 2571-8 |
| S | 1919-04-28 | Hemoglobin [Mass/volume] in Blood | 14.8 g/dL Reference 13.2-17.1 g/dL |
http://loinc.org · 718-7 |
| S | 1919-04-28 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 90 fL Reference 80-100 fL |
http://loinc.org · 787-2 |
| S | 1919-04-28 | Erythrocyte [DistWidth] in Blood by Automated count | 13.8% Reference 11-15% |
http://loinc.org · 788-0 |
| S | 1919-04-28 | Ferritin [Mass/volume] in Serum or Plasma | 64 ng/mL Reference 30-400 ng/mL |
http://loinc.org · 2276-4 |
| S | 1919-04-28 | Iron saturation [Mass Fraction] in Serum or Plasma | 27% Reference 20-50% |
http://loinc.org · 2502-3 |
| S | 1919-04-28 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | http://loinc.org · 44261-6 |
| S | 1919-04-28 | Total score [MoCA] | 28 | http://loinc.org · 72172-0 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 1919-01-13 | Body height | 183 cm | 8302-2 | S |
| 1919-01-13 | Body weight | 72.4 kg | 29463-7 | S |
| 1919-01-13 | Body mass index (BMI) [Ratio] | 21.6 kg/m2 | 39156-5 | S |
| 1919-01-13 | Systolic blood pressure | 124 mm[Hg] | 8480-6 | S |
| 1919-01-13 | Diastolic blood pressure | 66 mm[Hg] | 8462-4 | S |
| 1919-01-13 | Heart rate | 102 /min | 8867-4 | S |
| 1919-01-13 | Respiratory rate | 18 /min | 9279-1 | S |
| 1919-01-13 | Body temperature | 36.7 Cel | 8310-5 | S |
| 1919-01-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
| 1919-01-21 | Body height | 183 cm | 8302-2 | S |
| 1919-01-21 | Body weight | 72.6 kg | 29463-7 | S |
| 1919-01-21 | Body mass index (BMI) [Ratio] | 21.7 kg/m2 | 39156-5 | S |
| 1919-01-21 | Systolic blood pressure | 122 mm[Hg] | 8480-6 | S |
| 1919-01-21 | Diastolic blood pressure | 68 mm[Hg] | 8462-4 | S |
| 1919-01-21 | Heart rate | 94 /min | 8867-4 | S |
| 1919-01-21 | Respiratory rate | 16 /min | 9279-1 | S |
| 1919-01-21 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1919-01-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
| 1919-02-17 | Body height | 183 cm | 8302-2 | S |
| 1919-02-17 | Body weight | 73.4 kg | 29463-7 | S |
| 1919-02-17 | Body mass index (BMI) [Ratio] | 21.9 kg/m2 | 39156-5 | S |
| 1919-02-17 | Systolic blood pressure | 126 mm[Hg] | 8480-6 | S |
| 1919-02-17 | Diastolic blood pressure | 72 mm[Hg] | 8462-4 | S |
| 1919-02-17 | Heart rate | 80 /min | 8867-4 | S |
| 1919-02-17 | Respiratory rate | 16 /min | 9279-1 | S |
| 1919-02-17 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1919-02-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1919-03-10 | Body height | 183 cm | 8302-2 | S |
| 1919-03-10 | Body weight | 74 kg | 29463-7 | S |
| 1919-03-10 | Body mass index (BMI) [Ratio] | 22.1 kg/m2 | 39156-5 | S |
| 1919-03-10 | Systolic blood pressure | 128 mm[Hg] | 8480-6 | S |
| 1919-03-10 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 1919-03-10 | Heart rate | 74 /min | 8867-4 | S |
| 1919-03-10 | Respiratory rate | 14 /min | 9279-1 | S |
| 1919-03-10 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1919-03-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1919-04-28 | Body height | 183 cm | 8302-2 | S |
| 1919-04-28 | Body weight | 74.6 kg | 29463-7 | S |
| 1919-04-28 | Body mass index (BMI) [Ratio] | 22.3 kg/m2 | 39156-5 | S |
| 1919-04-28 | Systolic blood pressure | 128 mm[Hg] | 8480-6 | S |
| 1919-04-28 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 1919-04-28 | Heart rate | 70 /min | 8867-4 | S |
| 1919-04-28 | Respiratory rate | 14 /min | 9279-1 | S |
| 1919-04-28 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1919-04-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1919-03-24 | Body height | 183 cm | 8302-2 | S |
| 1919-03-24 | Body weight | 74.2 kg | 29463-7 | S |
| 1919-03-24 | Body mass index (BMI) [Ratio] | 22.2 kg/m2 | 39156-5 | S |
| 1919-03-24 | Systolic blood pressure | 126 mm[Hg] | 8480-6 | S |
| 1919-03-24 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 1919-03-24 | Heart rate | 72 /min | 8867-4 | S |
| 1919-03-24 | Respiratory rate | 14 /min | 9279-1 | S |
| 1919-03-24 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1919-03-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1919-02-03 | Body height | 183 cm | 8302-2 | S |
| 1919-02-03 | Body weight | 72.8 kg | 29463-7 | S |
| 1919-02-03 | Body mass index (BMI) [Ratio] | 21.7 kg/m2 | 39156-5 | S |
| 1919-02-03 | Systolic blood pressure | 124 mm[Hg] | 8480-6 | S |
| 1919-02-03 | Diastolic blood pressure | 70 mm[Hg] | 8462-4 | S |
| 1919-02-03 | Heart rate | 88 /min | 8867-4 | S |
| 1919-02-03 | Respiratory rate | 16 /min | 9279-1 | S |
| 1919-02-03 | Body temperature | 36.7 Cel | 8310-5 | S |
| 1919-02-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Retired naval officer and civil engineer, and a polar explorer who led eight Arctic expeditions; writes and lectures on polar travel; the long public dispute over his claim to have reached the North Pole still weighs on him
- S Lives in Washington, D.C., with his wife; two adult children; spends summers at a family house on an island off the Maine coast
- S Never used tobacco; a glass of wine with dinner a few times a week (AUDIT-C 2); eats a mixed diet with meat and dairy most days
- S Walked several miles a day until the autumn; now tires after a few blocks and uses a stick outdoors; wears made-to-measure boots with toe fillers
- S Strengths: physical toughness, careful planning and record-keeping, a long habit of looking after his feet in hard conditions, and a household that supports him
Functional status
- S Independent in daily activities but slowed: breathless on one flight of stairs, tires after a few blocks, unsteady in the dark and when washing his face with his eyes closed; one fall a month ago without injury; Timed Up and Go 14 seconds
Mental status
- S Alert, direct and orderly; speech normal; mood flat with tiredness; PHQ-9 6 with item 9 scored 0; MoCA 27; no thoughts of self-harm
Allergies and medications
Allergies
- S No known allergy
Medications
- S Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection every other day for seven doses, given by the clinic nurse after the intake blood tests were drawn
- S Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection once a week while the nerves recover
- S Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection once a month for life
- S Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet every other day on an empty stomach with a glass of orange juice
Procedures and immunizations
Procedures
- S Upper endoscopy with biopsies by the updated Sydney protocol (two from the antrum, one from the incisura, two from the body, each site in a separate jar) and targeted biopsies: pale, thin body mucosa with visible vessels and no polyp or mass; antrum normal
- S Screening colonoscopy, done at the same session: complete to the cecum, good preparation, no polyps or bleeding source
- S Advance care planning conversation, about 20 minutes
Immunizations
- S 1919-03-24: Recombinant zoster vaccine, first of two doses
- S 1919-03-24: Pneumococcal conjugate vaccine (PCV20), single dose
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D July 11, 1891: Both bones of one leg broken just above the ankle in a shipboard accident; set and healed (CLM-0004)
- D January to March 1899: Frostbite of both feet in the Arctic, followed by amputation of most of the toes; stumps often injured on later journeys (CLM-0006)
Family history
- D father: Died when his son was under three; cause not recorded in the cited source
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Find the cause of the anemia and the numb feet | 1919-01-21 | completed | Pernicious anemia confirmed: intrinsic factor and parietal cell antibodies positive, gastrin high |
| Normal hemoglobin and MCV within eight weeks | 1919-03-10 | completed | Hemoglobin 8.2 to 14.1 g/dL and MCV 118 to 91 fL at eight weeks |
| Recover feeling and balance in the feet and walk without falls | 1919-10-27 | active | At fifteen weeks: vibration sense back at the ankles, Romberg negative, Timed Up and Go 10 seconds, no falls; numbness at the ends of the feet persists |
| No foot wound that goes unnoticed | 1919-10-27 | active | Daily foot checks; one blister found early and healed in two weeks; podiatry every three months |
| Gastric surveillance planned with him | 1919-03-10 | completed | Endoscopy without neuroendocrine tumor or dysplasia; repeat in three years by shared decision |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Diagnosis: blood count with MCV, smear and reticulocytes; vitamin B12, methylmalonic acid, homocysteine and folate; iron studies, LDH and bilirubin; kidney function; TSH and HbA1c; all drawn before the first injection | completed | GL-BSH-B12-2014, GL-NICE-B12-2024, GL-CMID-2026 |
| Hematology consultation to confirm the cause and advise on treatment, endoscopy and follow-up | completed | GL-BSH-B12-2014, GL-AGA-AG-2021 |
| Treatment started at intake without waiting for the cause, because of neurological signs: cyanocobalamin 1,000 micrograms into the muscle every other day for seven doses; no folic acid alone; no transfusion while he is stable at rest | completed | GL-BSH-B12-2014, GL-NICE-B12-2024 |
| Maintenance: weekly injections, taught for self-injection, until neurological improvement levels off, then monthly injections for life; high-dose oral cyanocobalamin (at least 1 mg a day) offered as an alternative; vitamin B12 levels not rechecked routinely once treated | completed | GL-BSH-B12-2014, GL-NICE-B12-2024, GL-CMID-2026 |
| Response and safety checks: reticulocytes and potassium in the first week, blood count at about five and eight weeks, methylmalonic acid and homocysteine and iron studies at eight weeks, and symptoms at every visit | completed | GL-CMID-2026, GL-BSH-B12-2014 |
| Stomach: upper endoscopy with biopsies by the updated Sydney protocol to confirm autoimmune gastritis and look for neuroendocrine tumors and dysplasia, with a screening colonoscopy at the same session; surveillance interval set from the findings by shared decision; thyroid antibodies checked | completed | GL-AGA-AG-2021, GL-NICE-B12-2024, GL-USPSTF-CRC-2021 |
| Nerves and falls: neurological examination (vibration, joint position, reflexes, Romberg, gait, cognition) at each visit; physical therapy for balance and gait; night lights and a clear path at home; a stick outdoors and care on ice | completed | GL-CMID-2026, GL-USPSTF-FALLS-2024 |
| Feet: daily skin checks with a mirror, extra-depth shoes with toe fillers and a forefoot rocker sole, no new boots without a fitting, nail and callus care by podiatry every three months, and same-day care for any blister, redness or wound | completed | GL-IWGDF-2023 |
| Mood and cognition: PHQ-9 and MoCA at intake and after treatment, since vitamin B12 deficiency can affect both | completed | GL-CMID-2026, GL-USPSTF-DEP-2023, GL-NICE-B12-2024 |
Planned encounters
- 1919-01-13 — Establishing primary care for four months of fatigue, breathlessness, pallor, a sore tongue, and numbness and unsteadiness in the feet: blood tests, neurological and foot examination, falls, mood, the first vitamin B12 injection and a hematology consultation (ENC-001)
- 1919-01-21 — Eight-day review with the reticulocyte response and potassium, seen the same day by hematology: the cause, the injection plan, endoscopy, autoimmune screening and the nerves (ENC-002)
- 1919-02-03 — Same-day sick visit for a blister on the left forefoot (ENC-007, unscheduled)
- 1919-02-17 — Five-week review on the day of upper endoscopy and colonoscopy: blood count, nerves, falls and feet (ENC-003)
- 1919-03-10 — Eight-week review: blood count, methylmalonic acid, iron studies, the endoscopy biopsies and surveillance (ENC-004)
- 1919-03-24 — Periodic adult preventive visit (ENC-006)
- 1919-04-28 — Fifteen-week review: neurological recovery, iron, lifelong maintenance and the plan ahead (ENC-005)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Sick Visit
- Progress note 04 — Focused Visit (Follow-up)
- Progress note 05 — Focused Visit (Follow-up)
- Progress note 06 — Preventive Visit
- Progress note 07 — Focused Visit (Care-plan review)
- Hematology referral
- Hematology consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Sick Visit (XML)
- Progress note 04 — Focused Visit (Follow-up) (XML)
- Progress note 05 — Focused Visit (Follow-up) (XML)
- Progress note 06 — Preventive Visit (XML)
- Progress note 07 — Focused Visit (Care-plan review) (XML)
- Hematology referral (XML)
- Hematology consultation (XML)
Sources
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check treatment before the antibody results, the intramuscular cyanocobalamin schedule and lifelong maintenance, the potassium check, no transfusion, the antibody tests drawn after the first injections, the endoscopy findings and three-year surveillance, iron deficiency after recovery, the neurological examination and its partial recovery, and the foot-care plan for old toe amputations. |
| provenance review | not_started | Sources: the Peary-MacMillan Arctic Museum (Bowdoin College) biography, Polar Pathways exhibit pages and Minik exhibit, Weems (Arctic 1982) and LeMoine (Arctic 2014) in full text, the University of New England finding aid for his daughter's papers, Arlington National Cemetery, and the Nobel Prize page. The roster's rheumatoid arthritis and psychological burden leads are not used as diagnoses. |
| safe messaging review | not_started | His bringing six Inughuit people to New York, four of whom died, and his two sons with an Inughuit woman are recorded plainly and respectfully as documented history; no health fact about any Inuit person is recorded, no descendant is named, and none has a role in the modern episode. Matthew Henson and the four Inughuit men are named only as documented companions. No relative is named or given a role in the modern episode. PHQ-9 6 and then 2 with item 9 scored 0, so no safety assessment is required. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.